Ozempic pens come in three different strengths, each containing 3 mL of solution (in addition to the drug semaglutide, the solution contains stabilizers, water, and other inactive ingredients): The 2.0 mg pen can deliver 0.25 mg or 0.5 mg of semaglutide per injection
According to the FDA prescribing information for both Ozempic and Wegovy, nausea, vomiting, diarrhea, abdominal pain, and constipation occur in a significant proportion of patients, particularly during dose escalation
Hypoglycemia risk remains low with this combination when used without insulin or sulfonylureas, as both medications have glucose-dependent mechanisms
Both cause gastrointestinal symptoms primarily during dose escalation
Tirzepatide, also known as Zepbound, is a medication that is approved by the FDA for weight loss in people who are obese (with a body mass index (BMI) over 30 kg/m2) or overweight (BMI over 27 kg/m2) with medical conditions such as diabetes or heart disease
#5: Holding and Removing the Needle Hold Steady: After administering the dose, hold the pen in place for a few seconds to allow the medication to be absorbed